1. Home
  2. NAII vs ICCC Comparison

NAII vs ICCC Comparison

Compare NAII & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

N/A

Current Price

$2.00

Market Cap

15.8M

Sector

Health Care

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$9.62

Market Cap

93.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NAII
ICCC
Founded
1980
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8M
93.1M
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
NAII
ICCC
Price
$2.00
$9.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.3K
16.2K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.85
EPS
N/A
0.41
Revenue
$132,437,000.00
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$23.37
Revenue Growth
8.60
51.64
52 Week Low
$1.94
$4.52
52 Week High
$4.96
$12.10

Technical Indicators

Market Signals
Indicator
NAII
ICCC
Relative Strength Index (RSI) 38.69 34.65
Support Level N/A $9.55
Resistance Level $2.49 $10.75
Average True Range (ATR) 0.12 0.24
MACD -0.01 -0.00
Stochastic Oscillator 15.26 9.53

Price Performance

Historical Comparison
NAII
ICCC

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: